Skip to main content
. 2016 Mar 1;22(3):146–152. doi: 10.5761/atcs.oa.15-00301

Table 2.

Comparison of comorbidities between the AFL(+) and AFL(–) groups

  Total (n = 3667) n (%) AFL (+) (n = 738) n (%) AFL (–) (n = 2929) n (%) Odds ratio for AFL (95% CI) P value*

Hypertension 856 (23.2) 210 (28.5) 646 (22.1) 1.41 (1.17–1.70) 0.0003
Dyslipidemia 280 (7.6) 63 (8.5) 217 (7.4) 1.16 (0.85–1.57) 0.3141
Diabetes mellitus 409 (11.1) 104 (14.1) 305 (10.4) 1.42 (1.11–1.81) 0.0048
Cardiac diseases 476 (12.9) 157 (21.3) 319 (10.9) 2.22 (1.78–2.75) <0.0001
COPD 200 (5.4) 132 (17.9) 68 (2.3) 9.17 (6.70–12.6) <0.0001
Bronchial asthma 99 (2.7) 35 (4.7) 64 (2.2) 2.23 (1.42–3.46) <0.0001
Interstitial pneumonia 192 (5.2) 30 (4.1) 162 (5.5) 0.75 (0.49–1.12) 0.1664
CNS diseases 149 (4.1) 48 (6.5) 101 (3.4) 3.45 (1.34–2.81) 0.0004
Malignant diseases 813 (22.1) 168 (22.8) 645 (22.0) 1.04 (0.85–1.26) 0.7278
CVD 110 (3.0) 11 (1.5) 99 (3.4) 0.43 (0.21–0.82) 0.0053
Renal diseases 68 (1.8) 13 (1.8) 55 (1.9) 0.94 (0.47–1.75) 1.0000

*Fisher’s exact test was utilized to test a statistical significance between AFL(+) and AFL(–) group. Cardiac diseases include previous myocardial infarction, angina pectoris, cardiomyopathy, valvular diseases and aortic aneurysm. Central nervous system diseases include cerebral infarction, transient ischemic attack, Parkinson’s disease and other degenerative diseases. AFL: airflow limitation; COPD: chronic obstructive pulmonary disease; CNS: central nervous system; CVD: collagen vascular diseases; 95% CI: 95% confidence interval